SEC Filings - MiNK Therapeutics

Form	Description	Filing date	View
EFFECT	EFFECT	Nov 08, 2022	View HTML 9999999995-22-003237.pdf 9999999995-22-003237.rtf 9999999995-22-003237.xls
CORRESP	CORRESP	Nov 07, 2022	View HTML 0001193125-22-278982.pdf 0001193125-22-278982.rtf 0001193125-22-278982.xls
UPLOAD	UPLOAD	Nov 07, 2022	View HTML 0000000000-22-012111.pdf 0000000000-22-012111.rtf
10-Q	Quarterly report which provides a continuing view of a company's financial position	Nov 03, 2022	View HTML 0000950170-22-021565.pdf 0000950170-22-021565.rtf 0000950170-22-021565.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
8-K	Report of unscheduled material events or corporate event	Nov 03, 2022	View HTML 0001171843-22-007046.pdf 0001171843-22-007046.rtf 0001171843-22-007046.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
S-3	Simplified registration form	Nov 03, 2022	View HTML 0001193125-22-277009.pdf 0001193125-22-277009.rtf 0001193125-22-277009.xls
4	Statement of changes in beneficial ownership of securities	Sep 19, 2022	View HTML 0000899243-22-031523.pdf 0000899243-22-031523.rtf 0000899243-22-031523.xls
4	Statement of changes in beneficial ownership of securities	Sep 19, 2022	View HTML 0000899243-22-031529.pdf 0000899243-22-031529.rtf 0000899243-22-031529.xls
4	Statement of changes in beneficial ownership of securities	Sep 19, 2022	View HTML 0000899243-22-031530.pdf 0000899243-22-031530.rtf 0000899243-22-031530.xls
4	Statement of changes in beneficial ownership of securities	Sep 19, 2022	View HTML 0000899243-22-031528.pdf 0000899243-22-031528.rtf 0000899243-22-031528.xls

Data provided by Kaleidoscope.